Vector-directed immunity and boosting capacity of VRP-srRNA anti-tumor vaccines
Xingru Ma(Duke University), Zachary C. Hartman(Duke Medical Center)
Cited by 0
Related Papers
HER2 Overexpression Elicits a Proinflammatory IL-6 Autocrine Signaling Loop That Is Critical for Tumorigenesis
|Cancer Research|2011|136
HER2-LAMP vaccines effectively traffic to endolysosomal compartments and generate enhanced polyfunctional T cell responses that induce complete tumor regression
|Journal for ImmunoTherapy of Cancer|2020|19
Overcoming Xenoantigen Immunity to Enable Cellular Tracking and Gene Regulation with Immune-competent “NoGlow” Mice
|Cancer Research Communications|2024|9
Vaccination Against Androgen Receptor Splice Variants to Immunologically Target Prostate Cancer
|Vaccines|2024|6
Endogenous neoantigen-specific antibodies mediate antitumor responses and determine vaccine efficacy
|Journal for ImmunoTherapy of Cancer|2026|0